Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) traded down 5.2% on Thursday . The company traded as low as $6.97 and last traded at $6.97. 1,273 shares traded hands during trading, a decline of 13% from the average session volume of 1,462 shares. The stock had previously closed at $7.35.
Aspen Pharmacare Price Performance
The stock has a 50-day moving average of $6.02 and a two-hundred day moving average of $6.02. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.18 and a current ratio of 2.21.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
See Also
- Five stocks we like better than Aspen Pharmacare
- Trump’s AI Secret: 100X Faster Than Nvidia
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- The Crash Has Already Started (Most Just Don’t See It Yet)
- New gold price target
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
